News outlets also detail the latest expansion news from Oklahoma, Iowa, Georgia, Louisiana, Maine and Arizona.
[More]
Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.
[More]
Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.
[More]
The Ohio House is dropping expansion from Gov. John Kasich's budget while he says hospitals and other stakeholders must help in the effort to expand the health care program for low-income people. Meanwhile, supporters of an expansion try to rally support in Arkansas.
[More]
The Children's Hospital of Philadelphia and Pfizer, Inc., are joining forces with the goal of translating biomedical discoveries into novel treatments.
[More]
Pfizer Inc. announced today that the Japanese Ministry of Health, Labor and Welfare has approved XELJANZ (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis who have had an inadequate response to existing therapies.
[More]
The osteocutaneous radial forearm free flap should be used for mandibular reconstruction because of the low rate of long-term donor and recipient site complications, particularly with prophylactic plating of the donor radius, say US scientists.
[More]
Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.
[More]
The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC).
[More]
Ayurvedic medicine may offer osteoarthritis relief, say Indian researchers who found traditional formulations to be equal to conventional drugs for the improvement of pain and knee function.
[More]
Surgery is not always necessary for acute anterior cruciate ligament injury in young, active patients, research suggests.
[More]
A report by the Commonwealth Fund finds that 39 states do not have measures to allow officials to enforce some key insurance regulations from the federal health law.
[More]
AACN Certification Corporation has launched the new ACNPC-AG certification exam, which aligns with the requirements of the Consensus Model for APRN Regulation.
[More]
Tofacitinib treats symptoms and prevents structural damage in patients with rheumatoid arthritis who do not respond well to methotrexate, indicate phase III trial findings.
[More]
Injury risk is high for downhill mountain bikers, but could be reduced by ensuring trails are in good condition and improving rider technique, say researchers.
[More]
Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.
[More]
Animal scientists in Brazil have found that a small dose of the feed additive ractopamine can boost pork production without changing how pork looks or tastes.
[More]
The benefit of taking vitamin D supplements for the treatment of knee osteoarthritis has been challenged in a study published in JAMA.
[More]
Study findings confirm suspicions that patients with diabetes have an increased risk for adhesive capsulitis of the shoulder.
[More]
Ultrasound screening for developmental dysplasia of the hip is unnecessary in twins and triplets without signs of the condition, say UK researchers.
[More]